Provectus Pharmaceuticals, Inc. (PVCT.OB) Brings in $7.5M in a Private Placement

By Jonathan
12 March 2010 @ 08:40 am EDT

Provectus Pharmaceuticals, Inc., a developer of oncology and dermatology treatments, today announced gross proceeds of approximately $7.5M from a private placement. With intentions to apply the capital generated by this private placement to working capital concerns, PVCT CFO and COO Peter Culpepper noted that the closing of this offer has tremendously strengthened the Company’s operational activities and widely expanded PVCT’s base of shareholders “to include new and individual investors”.

Small Cap News in collaboration with Quality Stocks

E-Newsletters

We value your privacy. Your email address will not be shared.

Home
World
US
Economy
Companies
Tech
Science
Global Markets
Education
Real Estate
Forex
Commodities
Gold & Silver Matters
More Sections
Fashion
Auto
Travel
Health
Law
Entertainment
Sports
Luxury
Art
Books
Tech & Trend
Tools & Features
Topics
Blogs
Market Data
Stock Watch List
Investment Calculator
Financial Glossary
Broker Center
World Business Headlines
Updates
RSS Feeds
IBTimes on Twitter
IBTimes on Facebook
E-Newsletters
Services
Forex Newsfeed
Research
Press Release
About IBTimes
News Licensing
Media Kit
Advertise with Us
About IBTimes
Contact Us
Terms of Service
Privacy Policy